
European Society for Radiotherapy & Oncology (ESTRO)/LinkedIn
Oct 9, 2024, 11:08
Stereotactic Ablative Radiation trial results published in Red Journal – ESTRO
European Society for Radiotherapy & Oncology (ESTRO) posted the following on LinkedIn:
“Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial, published in the Red Journal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 22, 2025, 16:27
Mar 22, 2025, 14:55
Mar 22, 2025, 14:41
Mar 22, 2025, 14:28
Mar 22, 2025, 13:46
Mar 22, 2025, 13:29
Mar 22, 2025, 13:16
Mar 22, 2025, 12:47
Mar 22, 2025, 12:27
Mar 22, 2025, 12:06